WallStreetZenWallStreetZen

NASDAQ: AEMD
Aethlon Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AEMD

Based on 1 analyst offering 12 month price targets for Aethlon Medical Inc

Min Forecast
$1.50+98.94%
Avg Forecast
$1.50+98.94%
Max Forecast
$1.50+98.94%

Should I buy or sell AEMD stock?

Based on 1 analyst offering ratings for Aethlon Medical Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although AEMD's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates AEMD as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their AEMD stock forecasts and price targets.

AEMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-14

1 of 1

Forecast return on equity

Is AEMD forecast to generate an efficient return?

Company
-37.19%
Industry
26.17%
Market
-52.51%
AEMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AEMD forecast to generate an efficient return on assets?

Company
-24%
Industry
13.57%
AEMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AEMD earnings per share forecast

What is AEMD's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.98
Avg 2 year Forecast
-$0.57
Avg 3 year Forecast
-$0.49

AEMD revenue forecast

What is AEMD's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$8.9M
Avg 2 year Forecast
$24.0M

AEMD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AEMD$0.75$1.50+98.94%Hold
BJDX$1.55N/AN/A
VTAK$2.69N/AN/A
TIVC$3.08N/AN/A
NUWE$3.97N/AN/A
View Top Medical Device Stocks

Aethlon Medical Stock Forecast FAQ

Is Aethlon Medical Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AEMD) stock is to Hold AEMD stock.

Out of 1 analyst, 0 (0%) are recommending AEMD as a Strong Buy, 0 (0%) are recommending AEMD as a Buy, 1 (100%) are recommending AEMD as a Hold, 0 (0%) are recommending AEMD as a Sell, and 0 (0%) are recommending AEMD as a Strong Sell.

If you're new to stock investing, here's how to buy Aethlon Medical stock.

What is AEMD's earnings growth forecast for 2026-2028?

(NASDAQ: AEMD) Aethlon Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 11.27%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.2%.

Aethlon Medical's earnings in 2025 is -$12,578,507.On average, 2 Wall Street analysts forecast AEMD's earnings for 2026 to be -$5,132,454, with the lowest AEMD earnings forecast at -$7,926,069, and the highest AEMD earnings forecast at -$2,338,840. On average, 1 Wall Street analyst forecast AEMD's earnings for 2027 to be -$1,481,265, with the lowest AEMD earnings forecast at -$1,481,265, and the highest AEMD earnings forecast at -$1,481,265.

In 2028, AEMD is forecast to generate -$1,273,368 in earnings, with the lowest earnings forecast at -$1,273,368 and the highest earnings forecast at -$1,273,368.

What is AEMD's revenue growth forecast for 2030-2031?

(NASDAQ: AEMD) Aethlon Medical's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.

Aethlon Medical's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast AEMD's revenue for 2030 to be $23,050,567, with the lowest AEMD revenue forecast at $23,050,567, and the highest AEMD revenue forecast at $23,050,567.

In 2031, AEMD is forecast to generate $62,447,025 in revenue, with the lowest revenue forecast at $62,447,025 and the highest revenue forecast at $62,447,025.

What is AEMD's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: AEMD) forecast ROA is -24%, which is lower than the forecast US Medical Devices industry average of 13.57%.

What is AEMD's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AEMD price target, the average AEMD price target is $1.50, with the highest AEMD stock price forecast at $1.50 and the lowest AEMD stock price forecast at $1.50.

The Wall Street analyst predicted that Aethlon Medical's share price could reach $1.50 by Aug 14, 2026. The average Aethlon Medical stock price prediction forecasts a potential upside of 98.94% from the current AEMD share price of $0.75.

What is AEMD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AEMD) Aethlon Medical's current Earnings Per Share (EPS) is -$7.19. On average, analysts forecast that AEMD's EPS will be -$1.98 for 2026, with the lowest EPS forecast at -$3.05, and the highest EPS forecast at -$0.90. On average, analysts forecast that AEMD's EPS will be -$0.57 for 2027, with the lowest EPS forecast at -$0.57, and the highest EPS forecast at -$0.57. In 2028, AEMD's EPS is forecast to hit -$0.49 (min: -$0.49, max: -$0.49).

What is AEMD's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: AEMD) forecast ROE is -37.19%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.